Whit Mayo
Stock Analyst at Leerink Partners
(2.52)
# 2,253
Out of 5,129 analysts
152
Total ratings
52.58%
Success rate
10.65%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Downgrades: Market Perform | $25 → $14 | $15.53 | -9.85% | 11 | Dec 3, 2025 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $21.47 | -20.82% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $330.25 | -6.13% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $2.12 | +17.92% | 5 | Mar 31, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $10.51 | +4.71% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $11.24 | -28.83% | 2 | Nov 19, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $9.35 | +167.38% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $175.40 | +42.53% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $113.43 | -11.84% | 1 | Jul 10, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $40.06 | -62.56% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $278.91 | +100.78% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $231.32 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $131.61 | -26.30% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $294.73 | +13.66% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $531.47 | -46.19% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $15.00 | +166.67% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $21.59 | +80.64% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.05 | -26.83% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.38 | +7,792.66% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $226.35 | -75.70% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $88.18 | +98.46% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $20.39 | -6.82% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.37 | +18.69% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $289.89 | -29.97% | 2 | May 1, 2018 |
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Market Perform
Price Target: $25 → $14
Current: $15.53
Upside: -9.85%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $21.47
Upside: -20.82%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $330.25
Upside: -6.13%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $2.12
Upside: +17.92%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $10.51
Upside: +4.71%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $11.24
Upside: -28.83%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $9.35
Upside: +167.38%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $175.40
Upside: +42.53%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $113.43
Upside: -11.84%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $40.06
Upside: -62.56%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $278.91
Upside: +100.78%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $231.32
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $131.61
Upside: -26.30%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $294.73
Upside: +13.66%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $531.47
Upside: -46.19%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $15.00
Upside: +166.67%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $21.59
Upside: +80.64%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.05
Upside: -26.83%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.38
Upside: +7,792.66%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $226.35
Upside: -75.70%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $88.18
Upside: +98.46%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $20.39
Upside: -6.82%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.37
Upside: +18.69%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $289.89
Upside: -29.97%